Muriel Elhai1, Jerôme Avouac, André Kahan, Yannick Allanore. 1. Rheumatology A Dpt, Paris Descartes University, Sorbonne Paris Cite, Cochin Hospital, APHP, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France.
Abstract
OBJECTIVES: Several epidemiological studies have revealed the co-occurrence of other autoimmune diseases (AIDs) within patients with systemic sclerosis (SSc). However, some of these studies were based on small cohorts and wide ranges of prevalence have been reported. Therefore to overcome these limitations of individual studies, we sought to perform a meta-analysis to determine the accurate prevalence of polyautoimmunity in SSc. METHODS: We performed a systematic review and a meta-analysis of literature in MEDLINE and Embase databases from January 1960 to March 2013. All cohort studies reporting on prevalence of other AIDs known to be associated with SSc were analyzed. Prevalence of polyautoimmunity and of each AID were then calculated. RESULTS: Ten studies reporting polyautoimmunity were identified corresponding to a total of 6102 SSc patients. Overall 1432 patients with at least one AID were identified corresponding to a weighted prevalence of polyautoimmunity equal to 25.7% CI 95% [20.1%-31.6%]. Overall 208/5139 SSc-patients had at least two additional AIDs resulting in a weighted prevalence of 3.9% [3.3%-4.4%]. The most prevalent associated AIDs were autoimmune thyroid disease (10.4%) followed by Sjögren's syndrome (7.7%) and dermatopolymyositis/polymyositis (5.6%). CONCLUSION: Our results confirm that SSc polyautoimmunity is a frequent condition in SSc affecting a quarter of SSc-patients. The impact on the phenotype and also on the management and therapy will need to be addressed now in further works.
OBJECTIVES: Several epidemiological studies have revealed the co-occurrence of other autoimmune diseases (AIDs) within patients with systemic sclerosis (SSc). However, some of these studies were based on small cohorts and wide ranges of prevalence have been reported. Therefore to overcome these limitations of individual studies, we sought to perform a meta-analysis to determine the accurate prevalence of polyautoimmunity in SSc. METHODS: We performed a systematic review and a meta-analysis of literature in MEDLINE and Embase databases from January 1960 to March 2013. All cohort studies reporting on prevalence of other AIDs known to be associated with SSc were analyzed. Prevalence of polyautoimmunity and of each AID were then calculated. RESULTS: Ten studies reporting polyautoimmunity were identified corresponding to a total of 6102 SSc patients. Overall 1432 patients with at least one AID were identified corresponding to a weighted prevalence of polyautoimmunity equal to 25.7% CI 95% [20.1%-31.6%]. Overall 208/5139 SSc-patients had at least two additional AIDs resulting in a weighted prevalence of 3.9% [3.3%-4.4%]. The most prevalent associated AIDs were autoimmune thyroid disease (10.4%) followed by Sjögren's syndrome (7.7%) and dermatopolymyositis/polymyositis (5.6%). CONCLUSION: Our results confirm that SSc polyautoimmunity is a frequent condition in SSc affecting a quarter of SSc-patients. The impact on the phenotype and also on the management and therapy will need to be addressed now in further works.
Authors: Ludmila Klukova; Tomas Bertok; Miroslava Petrikova; Alena Sediva; Danica Mislovicova; Jaroslav Katrlik; Alica Vikartovska; Jaroslav Filip; Peter Kasak; Anita Andicsová-Eckstein; Jaroslav Mosnáček; Jozef Lukáč; Jozef Rovenský; Richard Imrich; Jan Tkac Journal: Anal Chim Acta Date: 2014-10-27 Impact factor: 6.558
Authors: Pia Moinzadeh; Elisabeth Aberer; Keihan Ahmadi-Simab; Norbert Blank; Joerg H W Distler; Gerhard Fierlbeck; Ekkehard Genth; Claudia Guenther; Ruediger Hein; Joerg Henes; Lena Herich; Ilka Herrgott; Ina Koetter; Alexander Kreuter; Thomas Krieg; Kathrin Kuhr; Hanns-Martin Lorenz; Florian Meier; Inga Melchers; Hartwig Mensing; Ulf Mueller-Ladner; Christiane Pfeiffer; Gabriela Riemekasten; Miklós Sárdy; Marc Schmalzing; Cord Sunderkoetter; Laura Susok; Ingo H Tarner; Peter Vaith; Margitta Worm; Gottfried Wozel; Gabriele Zeidler; Nicolas Hunzelmann Journal: Ann Rheum Dis Date: 2014-01-03 Impact factor: 19.103
Authors: Elena López-Isac; Jose-Ezequiel Martín; Shervin Assassi; Carmen P Simeón; Patricia Carreira; Norberto Ortego-Centeno; Mayka Freire; Emma Beltrán; Javier Narváez; Juan J Alegre-Sancho; Benjamín Fernández-Gutiérrez; Alejandro Balsa; Ana M Ortiz; Miguel A González-Gay; Lorenzo Beretta; Alessandro Santaniello; Chiara Bellocchi; Claudio Lunardi; Gianluca Moroncini; Armando Gabrielli; Torsten Witte; Nicolas Hunzelmann; Jörg H W Distler; Gabriella Riekemasten; Annette H van der Helm-van Mil; Jeska de Vries-Bouwstra; Cesar Magro-Checa; Alexandre E Voskuyl; Madelon C Vonk; Øyvind Molberg; Tony Merriman; Roger Hesselstrand; Annika Nordin; Leonid Padyukov; Ariane Herrick; Steve Eyre; Bobby P C Koeleman; Christopher P Denton; Carmen Fonseca; Timothy R D J Radstake; Jane Worthington; Maureen D Mayes; Javier Martín Journal: Arthritis Rheumatol Date: 2016-09 Impact factor: 10.995
Authors: Percival D Sampaio-Barros; Danieli C O Andrade; Luciana C P Seguro; Sandra G Pasoto; Vilma S T Viana; Ana C M Ribeiro; Nadia E Aikawa; Maria do Carmo S Timenetsky; Alexander R Precioso; Clóvis A Silva; Eloisa Bonfa Journal: Rheumatology (Oxford) Date: 2018-10-01 Impact factor: 7.580